HIV patients get extended access to experimental weekly injection
NCT ID NCT02990858
First seen Nov 12, 2025 · Last updated Apr 30, 2026 · Updated 23 times
Summary
This study gave HIV patients who had already completed an earlier trial continued access to a weekly injection of PRO 140 along with their regular HIV medications. The goal was to see if the drug could keep the virus under control and be safe over a longer period. A total of 43 people took part, but the study was stopped early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS (HIV) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.